1. Function and regulation of GPX4 in the development and progression of fibrotic disease
   Zhaobing Li et al, 2022, Journal of Cellular Physiology CrossRef
2. GPR116 promotes ferroptosis in sepsis-induced liver injury by suppressing system Xc–/GSH/GPX4
   Ying Wang et al, 2023, Cell Biology and Toxicology CrossRef
3. Programmed cell death, from liver Ischemia–Reperfusion injury perspective: An overview
   Shaobin Luo et al, 2024, Heliyon CrossRef
4. Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene
   Qi Sun et al, 2023, Communications Biology CrossRef
5. Bioinformatics analysis of genes related to ferroptosis in hepatic ischemia-reperfusion injury
   Shuo Sun et al, 2022, Frontiers in Genetics CrossRef
6. Mesenchymal stem cells and ferroptosis: Clinical opportunities and challenges
   Mengling Cui et al, 2024, Heliyon CrossRef
7. ERRFI1 exacerbates hepatic ischemia reperfusion injury by promoting hepatocyte apoptosis and ferroptosis in a GRB2-dependent manner
   Hang Zhao et al, 2024, Molecular Medicine CrossRef
8. Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/KCNQ1OT1 axis
   Shuangfa Zou et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
9. Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury (C57bl/6 Mouse)
   Sang Wook Kang et al, 2024, Transplantation Proceedings CrossRef
10. Discovery of ergosterol derivative from Aspergillus sp. TJ507 that protects against hepatic ischemia/reperfusion injury
    Hong Hu et al, 2023, Bioorganic Chemistry CrossRef
11. Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies
    Yongyi Liang et al, 2024, Phytomedicine CrossRef
12. Ghrelin ameliorates transformation of hepatic ischemia-reperfusion injury to liver fibrosis by blocking Smad and ERK signalling pathways, and promoting anti-inflammation and anti-oxidation effects
    Yang Yang et al, 2022, Transplant Immunology CrossRef
13. Editorial: Liver diseases and programmed cell death
    Peng Cao et al, 2023, Frontiers in Pharmacology CrossRef
14. Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway
    Mengting Zhan et al, 2024, Transplantation CrossRef
15. Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases
    Hongmei You et al, 2022, Cells CrossRef
16. An update on the molecular mechanism and pharmacological interventions for Ischemia-reperfusion injury by regulating AMPK/mTOR signaling pathway in autophagy
    Bin Tang et al, 2023, Cellular Signalling CrossRef
17. Targeting NF-κB in Hepatic Ischemia–Reperfusion Alleviation: from Signaling Networks to Therapeutic Targeting
    Rui-ming Deng et al, 2024, Molecular Neurobiology CrossRef
18. Ferroptosis-related exosomal non-coding RNAs: promising targets in pathogenesis and treatment of non-malignant diseases
    Yiping Zhang et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
19. O-sialoglycoprotein Endopeptidase (OSGEP) Suppresses Hepatic Ischemia-Reperfusion Injury-Induced Ferroptosis Through Modulating the MEK/ERK Signaling Pathway
    Yuanyuan Tao et al, 2024, Molecular Biotechnology CrossRef